Continuous renal replacement therapy with vitamin E-coated polysulfone hemofilter reduces inflammatory responses in a

Takumi Horikawa1, Kana Yagi1, Chika Ishikawa1

  • 1Medical Technology and Material Laboratory, Research and Business Development Division, Asahi Kasei Medical Co., LTD., Shizuoka, Japan.

Abstract

Insights

Vitamin E-coated polysulfone hollow fiber membranes (ViLIFE) show promise in managing inflammation during continuous renal replacement therapy (CRRT). This novel approach may improve patient outcomes by reducing inflammatory markers and biological invasions.

Area of Science:

  • Biomedical Engineering
  • Nephrology
  • Critical Care Medicine

Background:

  • Biological invasions can trigger systemic inflammatory response syndrome in patients undergoing continuous renal replacement therapy (CRRT), negatively impacting prognosis.
  • Investigating novel biocompatible materials is crucial for mitigating CRRT-associated inflammation.

Purpose of the Study:

  • To evaluate the efficacy of vitamin E-coated polysulfone hollow fiber membranes (ViLIFE) in modulating inflammatory responses during CRRT.
  • To assess the impact of ViLIFE on circulating inflammatory markers in an acute inflammation model.

Main Methods:

  • An acute inflammation model was induced in pigs via intravenous lipopolysaccharide administration.
  • Extracorporeal circulation was conducted for 6 hours using continuous venovenous hemodiafiltration with either standard polysulfone or ViLIFE hemofilters.
  • Inflammatory reactions were assessed by comparing marker levels between groups.

Main Results:

  • The ViLIFE group demonstrated significantly lower levels of platelets and cytokines compared to the sham-CRRT group (p < 0.05).
  • ViLIFE treatment resulted in reduced levels of lactate and high mobility group box 1 (HMGB1) compared to control groups.
  • These findings suggest a potent anti-inflammatory effect of the ViLIFE membrane.

Conclusions:

  • ViLIFE is a promising new modality for CRRT, effectively inhibiting systemic inflammatory responses.
  • The ViLIFE membrane shows potential in preventing further biological invasions associated with inflammation during CRRT.

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
420
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.4K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
548